Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway

A method of treating diabetic peripheral neuropathy, in a patient in need thereof comprising administering to the patient in need thereof a therapeutically effective amount of a compound of the formula:

• wherein:
• n is 1;
• Y1 is -alkanediyl(C≤6)-, —C(O)-alkanediyl(C≤6)-, or a substituted version of any of these groups;
• Y2 is O;
• R3 is —NR11R11′ or —C(O)NR12R12′, wherein:
• R11 and R11′ are each independently hydrogen, alkyl(C≤6), substituted alkyl(C≤6), acyl(C≤6), or substituted acyl(C≤6);
• R12 and R12′ are each independently hydrogen, alkyl(C≤6), or substituted alkyl(C≤6);
• R7 is alkyl(C≤6) or a substituted alkyl(C≤6);
• R8 is hydroxy, alkoxy(C≤6), or substituted alkoxy(C≤6);
• and
• R9 and R10 are each hydroxy;
• or a pharmaceutically acceptable salt of the formula.